These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1243828)

  • 1. [Criteria of the test of suppression of thyroid uptake of I131 by triiodothyronine].
    Aliiakparova ASh
    Probl Endokrinol (Mosk); 1975; 21(4):13-7. PubMed ID: 1243828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 3,5,3'-L-triiodothyronine (T3) on protein-bound iodine (PBI) and I131 uptake during the thyroid supression test in normal subjects and in non-toxic and toxic goiter patients].
    de Assis LM; Nicolau W; Pieroni RR; Mattar E
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Dec; 33(6):258-61. PubMed ID: 85324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnosis of diffuse toxic goiter and neurocirculatory dystonia].
    Trofimov GA; Reshetnev VG; Chizhik VA; Shurygina VD
    Voen Med Zh; 1988 Mar; (3):43-6. PubMed ID: 3388793
    [No Abstract]   [Full Text] [Related]  

  • 4. Iodinating activity of thyroid tissue in toxic diffuse goiter.
    Nagataki S; Uchimura H; Ikeda H; Kuzuya N; Masuyama Y
    J Clin Invest; 1977 Apr; 59(4):723-9. PubMed ID: 576614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of lithium carbonate in the therapy of diffuse toxic goiter].
    Pimenov LT
    Probl Endokrinol (Mosk); 1982; 28(1):26-32. PubMed ID: 6801641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of the triiodothyronine suppression test with serum T4 and thyroid 131I uptake as indexes in judging the prognosis of Graves' disease].
    Luo GC
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):154-6, 189. PubMed ID: 3094869
    [No Abstract]   [Full Text] [Related]  

  • 7. [Normalization of the functional regulation of the thyroid as a criterion of the remission of diffuse toxic goiter following antithyroid treatment].
    Khelds AO
    Probl Endokrinol (Mosk); 1986; 32(4):11-4. PubMed ID: 2429297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of the subclinical stages of diffuse toxic goiter].
    Baranov VG; Nikolaenko NF; Stepanov GS
    Probl Endokrinol (Mosk); 1974; 20(3):35-8. PubMed ID: 4141769
    [No Abstract]   [Full Text] [Related]  

  • 10. [The differential diagnosis of diffuse toxic goiter and neurocirculatory dystonia].
    Liashuk PM
    Lik Sprava; 1992 Jan; (1):92-4. PubMed ID: 1364623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Suppression of the thyroid gland using l-triiodothyronine. Dependence on function, iodine uptake, size of the thyroid gland and age].
    Heinze HG; Pabst HW; Sonntag A
    Munch Med Wochenschr; 1968 Aug; 110(34):1875-84. PubMed ID: 5695744
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interrelation of the thyroid and calcium-regulating functions in patients with diffuse toxic goiter].
    Karetnikov IuP; Vasil'eva IV
    Probl Endokrinol (Mosk); 1987; 33(5):23-7. PubMed ID: 3422931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the inhibitory effect of l-triiodo-thyronine on thyroidal I131 uptake in euthyroid persons and patients with exophthalmic goiter.
    MCCONAHEY WM; OWEN CA
    J Clin Endocrinol Metab; 1956 Nov; 16(11):1480-6. PubMed ID: 13385298
    [No Abstract]   [Full Text] [Related]  

  • 15. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.
    Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic value of the triiodothyronine-suppression-tes in thyroid gland diagnosis with radioactive iodine].
    Heinze HG; Pabst HW; Hör G; Frey KW; Sonntag A; Klemm J
    Nucl Med (Stuttg); 1967; ():271-8. PubMed ID: 5632456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diffuse hyperthyroid goiter treated with I131, papillary carcinoma occurring after iodine radioisotope treatment, and thyroxine malabsorption. A clinical case].
    Devoto E; Aravena L; Hidalgo MS; Gajardo H; Lioi X; Soto N; Barrera R; Munizaga F
    Rev Med Chil; 1991 Sep; 119(9):1046-9. PubMed ID: 1845099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remote results of long-term mercazolyl treatment combined with irradiation of the the hypothalamo-hypophyseal region in patients with diffuse toxic goiter].
    Baranov VG; Nikolaenko NF; Aleksandrovich EI
    Probl Endokrinol (Mosk); 1976; 22(3):37-40. PubMed ID: 59359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid suppression by triiodothyronine before and after treatment for Graves' disease.
    Hennemann G; Bussemaker JK
    Lancet; 1969 Mar; 1(7595):588-90. PubMed ID: 4180125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.